The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa

被引:12
|
作者
Jamieson, Lise [1 ,2 ]
Gomez, Gabriela B. [3 ]
Rebe, Kevin [4 ]
Ben Brown [4 ]
Subedar, Hasina [5 ]
Jenkins, Sarah [6 ]
Shoko, Natsai [7 ]
Bekker, Linda-Gail [8 ]
Johnson, Leigh F. [9 ]
Meyer-Rath, Gesine [1 ,2 ,10 ]
机构
[1] Hlth Econ & Epidemiol Res Off HE2RO, Johannesburg, South Africa
[2] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Johannesburg, South Africa
[3] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London, England
[4] ANOVA Hlth Inst, Cape Town, South Africa
[5] Natl Dept Hlth, Pretoria, South Africa
[6] Clinton Hlth Access Initiat, Philadelphia, PA USA
[7] Clinton Hlth Access Initiat, Pretoria, South Africa
[8] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa
[9] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa
[10] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA
基金
美国国家卫生研究院;
关键词
cost; cost-effectiveness analysis; high-risk populations; preexposure prophylaxis; South Africa; HETEROSEXUAL MEN; PREVENTION; INFECTION; WOMEN; TRANSMISSION; COUPLES;
D O I
10.1097/QAD.0000000000002486
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: We explored the impact and cost-effectiveness of preexposure prophylaxis (PrEP) provision to different populations in South Africa, with and without effective self-selection by individuals at highest risk of contracting HIV (through concurrent partnerships and/or commercial sex). Design and methods: We used a previously developed HIV transmission model to analyse the epidemiological impact of PrEP provision to adolescents, young adults, pregnant women, female sex workers (FSWs) and (MSM), and data from South African PrEP programmes to estimate the cost and cost-effectiveness of PrEP (cost in 2019 USD per HIV infection averted over 20 years, 2019, 38). PrEP uptake followed data from early implementation sites, scaled-up linearly over 3 years, with target coverage set to 18% for adolescents, young adults and pregnant women, 30% for FSW and 54% for MSM. Results: The annual cost of PrEP provision ranges between $75 and $134 per person. PrEP provision adolescents and young adults, regardless of risk behaviour, will each avert 3.2--4.8% of HIV infections over 20 years; provision to high-risk individuals only has similar impact at lower total cost. The incremental cost per HIV infection averted is lower in high-risk vs. all-risk sub-populations within female adolescents ($507 vs. $4537), male adolescents ($2108 vs. $5637), young women ($1592 vs. $10 323) and young men ($2605 vs. $7715), becoming cost saving within 20 years for high-risk adolescents, young women, MSM and FSWs. Conclusion: PrEP is an expensive prevention intervention but uptake by those at the highest risk of HIV infection will make it more cost-effective, and cost-saving after 14-18 years.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 50 条
  • [31] Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
    Fern Terris-Prestholt
    Anna M Foss
    Andrew P Cox
    Lori Heise
    Gesine Meyer-Rath
    Sinead Delany-Moretlwe
    Thomas Mertenskoetter
    Helen Rees
    Peter Vickerman
    Charlotte H Watts
    BMC Infectious Diseases, 14
  • [32] Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
    Terris-Prestholt, Fern
    Foss, Anna M.
    Cox, Andrew P.
    Heise, Lori
    Meyer-Rath, Gesine
    Delany-Moretlwe, Sinead
    Mertenskoetter, Thomas
    Rees, Helen
    Vickerman, Peter
    Watts, Charlotte H.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [33] Cost-effectiveness and budget impact analysis of peritoneal dialysis and haemodialysis in South Africa
    Evelyn Thsehla
    Micheal Kofi Boachie
    Susan Goldstein
    BMC Health Services Research, 25 (1)
  • [34] The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South Africa
    Gandhi, Aditya R.
    Hyle, Emily P.
    Scott, Justine A.
    Lee, Jasper S.
    Shebl, Fatma M.
    Joska, John A.
    Andersen, Lena S.
    O'Cleirigh, Conall
    Safren, Steven A.
    Freedberg, Kenneth A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 93 (04) : 333 - 342
  • [35] Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis
    Stone, Jack
    Bothma, Rutendo
    Gomez, Gabriela B.
    Eakle, Robyn
    Mukandavire, Christinah
    Subedar, Hasina
    Fraser, Hannah
    Boily, Marie-Claude
    Schwartz, Sheree
    Coetzee, Jenny
    Otwombe, Kennedy
    Milovanovic, Minja
    Baral, Stefan
    Johnson, Leigh F.
    Venter, Willem Daniel Francois
    Rees, Helen
    Vickerman, Peter
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26 (02)
  • [36] The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa
    Quaife, Matthew
    Terris-Prestholt, Fern
    Eakle, Robyn
    Escobar, Maria A. Cabrera
    Kilbourne-Brook, Maggie
    Mvundura, Mercy
    Meyer-Rath, Gesine
    Delany-Moretlwe, Sinead
    Vickerman, Peter
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 (03)
  • [37] The cost-effectiveness of multi- purpose HIV and pregnancy prevention technologies in South Africa
    Quaife, M.
    Terris-Prestholt, F.
    Eakle, R.
    Escobar, M. A. Cabrera
    Kilbourne-Brook, M.
    Mvundura, M.
    Meyer-Rath, G.
    Delany-Moretlwe, S.
    Vickerman, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 55 - 56
  • [38] The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
    Matsimela, Katleho
    Sande, Linda Alinafe
    Mostert, Cyprian
    Majam, Mohammed
    Phiri, Jane
    Zishiri, Vincent
    Madondo, Celeste
    Khama, Stephen
    Chidarikire, Thato
    d'Elbee, Marc
    Hatzold, Karin
    Johnson, Cheryl
    Terris-Prestholt, Fern
    Meyer-Rath, Gesine
    BMJ GLOBAL HEALTH, 2021, 6 (SUPPL_4):
  • [39] The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across eleven distribution models in South Africa
    Sande, L.
    Matsimela, K.
    Mostert, C.
    d'Elbee, M.
    Majam, M.
    Phiri, J.
    Zishiri, V.
    Madondo, C.
    Khama, S.
    Hatzold, K.
    Johnson, C.
    Chidarikire, T.
    Terris-Prestholt, F.
    Meyer-Rath, G.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 42 - 43
  • [40] A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men
    Drabo, Emmanuel F.
    Hay, Joel W.
    Vardavas, Raffaele
    Wagner, Zachary R.
    Sood, Neeraj
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (11) : 1495 - 1504